ESC Video reports from ACC 2010: Tendera, Verheugt, Di Mario, Wallentin and Ruschitzka

The ESC Communications Team attended ACC.10 in Atlanta, USA from 13 to 17 March, providing live coverage of the conference.

Date: 14 Mar 2010

I want the European take!

Thee reports here below focus primarily on the late breaking clinical trials by asking fellow European cardiologists to comment on what they've seen and heard, on the spot. This page includes reports by M. Tendera, F. Verheugt, C. di Mario, L. Wallentin and F.T. Ruschitzka.

F.T. Ruschitzka, FESC, comments the first set of late breaking clinical trials: .
ACCORD Blood Pressure Trial, INVEST study, ACCORD Lipid Study and NAVIGATOR

More ESC Video reports from ACC 2010 here.

Lars Wallentin, FESC, comments the late breaking clinical trials on arrhythmias.

Professor Carlo di Mario, FESC, comments on ACC.10 intervention trials.
CILON-T Study, "Optimal Duration of Dual Antiplatelet Therapy after DES Implantation".

Professor Freek Verheugt, FESC, comments on the interventional cardiology trials at ACC.10:
CILON-T Study and "Optimal Duration of Dual Antiplatelet Therapy after DES Implantation".

Past ESC President Professor Michal Tendera, Katowice, Poland, looks back at the last few days at ACC.10 and comments on his favourite lectures/sessions